How leptin, the 'satiety hormone,' reverses diabetes

June 16, 2014 by Helen Dodson, Yale University
How leptin, the ‘satiety hormone,’ reverses diabetes

(Medical Xpress)—Treatment with leptin, the hormone associated with fullness or satiety, reverses hyperglycemia in animals models of poorly controlled type 1 (T1D) and type 2 (T2D) diabetes by suppressing the neuroendocrine pathways that cause blood glucose levels to soar, a Yale-led team of researchers has found. The study appears in the Advance Online Publication of Nature Medicine.

The leptin hormone regulates metabolism, appetite, and body weight. The researchers discovered that, in a fasting state, rats with poorly controlled T1D and T2D diabetes had lower plasma insulin and leptin concentrations and large increases in concentrations of plasma corticosterone—a stress hormone made in the adrenal glands that raises levels of .

The researchers then found that normalizing plasma leptin concentrations in the T1D rats with a leptin infusion resulted in marked reductions in plasma , which could mostly be attributed to reduction in rates of liver conversion of lactate and amino acids into glucose.

The question was why this happened. The team's data revealed that leptin normalized plasma corticosterone and glucose concentrations by inhibiting the hypothalamic-pituitary-adrenal axis, a critical neuroendocrine pathway consisting of three major glands that regulate many body processes, including reactions to stress, energy storage, and energy utilization.

Researchers believe their finding about leptin may lead to development of new types of therapies to reduce and reverse uncontrolled hyperglycemia in patients with type 1 and type 2 diabetes.

"Previous studies by our group found that leptin replacement therapy reversed and insulin resistance in patients with severe lipodystophy—a loss of fatty tissue that leads to those disorders—by reducing fat deposits in the liver and skeletal muscle," said senior author Dr. Gerald Shulman, the George Cowgill Professor of Medicine (Endocrinology) and Cellular & Molecular Physiology, and a Howard Hughes Medical Institute investigator. "These new data provide an additional mechanism by which leptin therapy reverses hepatic insulin resistance and hyperglycemia in animal models of poorly controlled type 1 and ."

Explore further: Obesity gene linked to hormonal changes that favor energy surplus

More information: "Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis." Rachel J Perry, Xian-Man Zhang, Dongyan Zhang, Naoki Kumashiro, Joao-Paulo G Camporez, Gary W Cline, Douglas L Rothman & Gerald I Shulman. Nature Medicine (2014) DOI: 10.1038/nm.3579
Received 15 March 2014 Accepted 21 April 2014 Published online 15 June 2014

Related Stories

Obesity gene linked to hormonal changes that favor energy surplus

June 11, 2014
A new study from Uppsala University demonstrates that elderly humans carrying a common variant of the fat mass and obesity gene FTO also have a shifted endocrine balance. Low blood concentrations of the satiety hormone leptin ...

Leptin also influences brain cells that control appetite, study finds

June 1, 2014
Twenty years after the hormone leptin was found to regulate metabolism, appetite, and weight through brain cells called neurons, Yale School of Medicine researchers have found that the hormone also acts on other types of ...

Multihormone reverses metabolic damage of high calorie diet

January 15, 2014
Importantly, the scientists found out that treatment of obese mice with this GLP-1/Glucagon co-agonist improves metabolism and body weight associated with restored function of the weight lowering hormone leptin, even in the ...

A link between type 2 diabetes and mitochondrial function

October 1, 2013
Type 2 diabetes is a chronic condition that is characterized by resistance to or insufficient production of insulin, a hormone that controls sugar movement into cells. In certain tissues, insulin resistance has been associated ...

Researchers identify mechanisms that are necessary to live without insulin

September 3, 2013
Several millions of people around the world suffer from insulin deficiencies. Insulin is a hormone, secreted by the beta cells in the pancreas, which plays a major role in the regulation of energy substrates such as glucose. ...

Reversing key precursors to diabetes

November 6, 2013
Yale researchers have found a way to disrupt the biological underpinnings of disorders that predispose a person to type 2 diabetes (T2D), raising the possibility of developing therapies to reverse these conditions. The study ...

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.